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Abstract
Background. Fournier’s gangrene (FG) represents a necro-
tizing infection of the skin and subcutaneous soft tissue of
the external genitalia and perineum. It arises as a result of
propagation of anorectal, urogenital and skin infections. The
principles of treatment include improving general condition
of a patient, debridement of wound, excision of necrotic tis-
sue, combined antibiotic therapy, hyperbaric oxygen therapy
and reconstructive procedures. It is a rare but very serious
condition which regardless to aggressive treatment can lead to
a lethal outcome in up to 20−30% of patients. Case report.
Since the year 2000 we have treated six patients with FG. We
presented the course and positive treatment outcome in a 65-
year-old male patient with numerous comorbid conditions,
nonregulated insulin-dependent diabetes, hypertension, pre-
vious myocardial infarction, chronic viral hepatitis and
thrombocytopenia, rehabilitation was complicated with heart
failure, atrial fibrillation and pulmonary thromboembolism.
The treatment consisted of two extensive debridement of the
wound with removing necrotic tissue, drainage, consolidation
of state of health, correction of his blood sugar levels and
thrombocytopenia, antimycotic and combination of three an-
tibiotics and hyperbaric oxygen therapy. In two delayed surgi-
cal procedures reconstruction of a large defect of the urethra
was performed. Conclusion. A patient with numerous and
serious comorbid conditions with FG could recover as a re-
sult of teamwork of urologists, infective medicine specialists,
cardiologists, endocrinologist, vascular and plastic surgeons.
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Apstrakt
Uvod. Fournieova gangrena (FG) predstavlja nekrotizujuću
infekciju kože i potkožnog mekog tkiva spoljašnjih genitalija
i perineuma. Nastaje kao posledica širenja anorektalnih,
urogenitalnih ili kožnih infekcija. Princip lečenja FG podra-
zumeva stabilizaciju opšteg stanja bolesnika, debridman ra-
ne, odstranjivanje nekrotičnih promena, kombinovanu anti-
biotsku terapiju, oksigenoterapiju i eventualne rekonstrukti-
vne zahvate. Ovo je veoma retko, ali veoma ozbiljno stanje
koje uprkos agresivnoj terapiji, dovodi do letalnog ishoda
kod 20−30% obolelih. Prikaz bolesnika. U našoj ustanovi
od 2000. godine lečeno je šest bolesnika sa FG. Prikazujemo
tok i pozitivan ishod lečenja muškarca, starog 65 godina, sa
brojnim komorbidnim stanjima: neregulisanim dijabetesom
zavisnim od insulina, hipertenzijom, ranijim infarktom mio-
karda, hroničnom infekcijom virusom hepatitisa i trombo-
citopenijom čiji se oporavak komplikovao srčanom dekom-
penzacijom, atrijalnom fibrilacijom i plućnom tromboem-
bolijom. Lečen je primenom dva opsežna debridmana rane
uz uklanjanje nekrotičnih površina, drenaža, stabilizacija op-
šteg stanja, korekcija glikemije i trombocitopenije, antimi-
kotičkom i trojnom antibiotskom terapijom i hiperbaričnom
oksigenacijom. U dve odložene hirurške procedure učinjena
je rekonstrukcija velikog nedostajućeg dela uretre. Zaklju-
čak. Bolesnik sa brojnim i ozbiljnim komorbidnim stanjima,
oboleo od FG može se izlečiti timskim radom urologa, in-
fektologa, endokrinologa, kardiologa, vaskularnog i plastič-
nog hirurga.
Ključne reči:
furnijeova gangrena; dijagnoza; komorbiditet; lečenje;
hirurgija, urološka, procedure; hiperbarička
oksigenacija; lečenje, ishod.
Introduction
Fournier’s gangrene (FG) represents a necrotizing in-
fection of the skin and subcutaneous soft tissue of the exter-
nal genitalia and perineum
 1, 2. In 1764 Baurienne first de-
scribed this condition, but in 1883 Jean Alfred Fournier de-
fined it as an idiopathic, rapidly fulminating infection in pre-
viously healthy young patients and pointed out the known
predisposing factors for development of this type of gan-
grene
 1. In 11 patients, Wilson described FG as a type of nec-
rotizing fasciitis which involves superficial and deep fascia
of the perineum and surrounding structures
 1. In 1920, Mel-
ney first proposed surgical treatment for this type of gan-
grene
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with FG till 1996, and less than 2000 cases till today have
been cited. Mortality rate for FG is 4−67% in the reported se-
ries, and most authors reported 20−30%
 1, 3.
Fournier’s gangrene arises as a result of propagation of
anorectal, urogenital and skin infections. Propagation from
the anorectum is a result of injury or complication of malig-
nancy of this region, inflammation of perineal glands, diver-
ticulitis or appendicitis, perianal fistulas, hemorrhoid etc.
Urogenital causes of FG are inflammation of bulbourethral
glands, urethral injuries, urinary tract infection etc. A special
group consists of iatrogenic and noniatrogenic injuries of the
perineum. Skin infections of this region initially start as su-
purative hydroadenitis, ulceration of the scrotum, result of
trauma, complications of surgical procedures or intentional
trauma (popping or piercing). Beside these entrance sites for
infection, predisposing factors for FG are leukemia, Crohn’s
disease and human immunodeficiency virus (HIV) infection.
Diabetes mellitus, obesity, liver cirrhosis, vascular disease of
the pelvis minor, malignancies, alcoholism, intravenous drug
abuse and a prolonged use of steroids are recognized as
comorbid conditions which compromise the immune system
and are included in predisposing conditions for FG. This
fulminant and life-threatening infection develops when the
balance of the immune system of the host is compromised by
these comorbid conditions in the presence of virulent bacte-
rial strains
 1, 3, 4.
Case report
A patient, 65-year-old, was admitted in the Military
Medical Academy in November 2002 complaining of a pain-
ful, erythematous and swollen scrotum. Previously he had
episodes of frequent urination up to twenty times per day,
followed by irritation in the urethra and a feeling of inade-
quate emptying of the bladder and high temperature, up to
39 ºC. He was an insulin-dependent diabetic patient for over
twenty years and in the year 2 000 he had an acute myocar-
dial infarction. He was hepatitis C virus positive, had high
blood pressure with leukocytosis and thrombocytopenia. In
the inguinal region there were palpable bilateral enlarged
lymph nodes up to 2 cm. The penis was swollen, livid and
the foreskin could not be retracted over the glans. The scro-
tum was also swollen, livid with two charcoal grey necrotic
lesions near the root of the penis and the lower part of the
right hemiscrotum covering about 1/3 of the hemiscrotum
(Figure 1). The prostate was impossible to palpate due to
very intensive pain that the patient had during digitorectal
examination. At the time of admittance he was febrile
(38 ºC), pale, in a very serious condition. Laboratory find-
ings were full blood count (FBC): leukocytes 17.9  × 10
9,
thrombocytes 59  × 10
9, glucose 26.4 mmol/l. In the urine
culture Morganella morganii was later isolated in a signifi-
cant number. Immediate debridement of necrotic lesions of
the scrotum and inguinal regions bilaterally was performed
with lavage and drainage with multiple ripped drains and the
testes were dislocated under the skin of both inguinal re-
gions. Because the severity of the necrosis most of the penile
and scrotal skin was removed (Figures 2). During catheteri-
zation, before the operation the stricture of the bulbar urethra
was identified, after catheterization with a rigid Tiemann tip
catheter a periurethral abscess at the level of the stricture was
drained. We evacuated 800 ml of clear yellow residual urine.
Immediately after the hospitalization and prior to the surgical
procedure a combination of three iv antibiotics (ceftazidime,
metronidazole and amikacin) were introduced. Five days af-
ter the primary surgical procedure a necrectomia of devital-
ized skin was preformed. The immediate postoperative pe-
riod was complicated by atrial fibrillation, pulmonary throm-
boembolism and acute heart failure. For this reason, he was
under conservative treatment for five days in the Emergency
 
Fig. 2 − After necrectomia and debridement of the wound
Fig. 1 − Necrotic lesions on the scrotum at the time of
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Clinic for Internal Diseases, Military Medical Academy. The
patient was under constant supervision of the urologist, en-
docrinologist and cardiologist. Besides antibiotics he re-
ceived antimycotic therapy (fluconasole) and iv substitution
of liquid, albumin and plasma. His therapy with diuretics,
anticoagulants, sedatives and cardiotonics was continued.
His blood glucose levels were controlled daily with the cor-
rection of his insulin doses. His dressing was changed 3−5
times a day with debridement of the wound. He was isolated.
At least once a week laboratory results and swabs of the
wound were taken with the correction of his therapy. Eight
days after the initial surgical intervention the swab was posi-
tive for Echerichia coli and Acinobacter species and the he-
moculture showed the presence of coagulase negative and
gold Staphylococcus. The antibiotics were changed due to
these results and with consultation of the infective medicine
specialists. During the first hospital stay that lasted 58 days
and when the patient became stable and the wound status
improved, we treated him with hyperbaric oxygen therapy
(HBO) in ten 60-minute sessions under the pressure of 2 at-
mospheres absolutes (2 ATA).
After five months of primary surgery the patient got a
fistula on the midpart of the penile urethra, about 4 cm from
the external meatus, through which the entire urine passed
during urination. Six months after the fistula had appeared,
we performed a reconstruction of the penile urethra by the
transposition of the prepuce, but the graft failed and the fis-
tula occurred again, this time in the penoscrotal region.
Twelve months after the primary reconstruction of the ure-
thra, we performed a second one. We found a defect in the
posterior wall of the urethra in the length of about 7 cm from
the penoscrotal region and up to 4 cm from the external
meatus (Figures 3). After the use of on lay urethroplasty cum
inner tight flap (Figures 4), and the urine removal from the
bladder with a cystostomy catheter, the urethra defect nor-
malized, and the patient was recovered fully.
Discussion
Even today Fournier’s gangrene represents a rare but a
very serious disease with a high mortality rate. The patho-
physiological theories on the development of Fournier’s gan-
grene include the necrosis of the superficial and deep fascia,
fibrinous coagulation in the hole of the nutritive arterioles and
the infiltration of the polymorphonuclears. Anaerobic organ-
isms can give rise to the production of gas
 1. The most com-
mon causes of Fournier’s gangrene are Streptococcus species,
Staphylococcus species, Enterobacteriaceae species, Bac-
teroides and anaerobic bacteria and fungus
 1, 3. Nowadays, it is
assumed that Fournier’s gangrene occurs as a result of polymi-
crobic infection, where microorganisms synergistically pro-
duce enzymes that bring to a rapid spreading of infection.
The clinical signs and symptoms of Fournier’s gangrene
involve the presence of intensive pain, redness and the swel-
ling of the affected parts of the cutis and subcutis, genital and
  
Fig. 3 −  The urethra defect in the length of 7 cm that was reconstructed 12 months
after the primary reconstruction
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perianal region usually followed by a high body temperature.
The skin changes go through all of the phases of the necrosis
development with a possible purulent secretion from the
wound. Infection can spread between the Scarpa’s fascia and
the fascia from the external abdomen muscles, up to the cla-
viculas. Subskin crepitations are possible. Systemic symptoms
and signs of the disease are high body temperatures, shivering,
till the development of septic shock
 1. A great number of pa-
tients that suffer from Fournier’s gangrene have diabetes,
which is explained by the changes at micro-level in blood ves-
sels (diabetic microangiopathy)
 5. On the other hand, diabetics
have a lower phagocyte activity and a neutrophiles dysfunc-
tion exists, which helps the infection to spread
 6.
The principles of Fournier’s gangrene treatment consist
of stabilization of a patient, parenteral usage of wide specter
antibiotics and an early and aggressive surgical intervention,
and after that hyperbaric oxygenation if it’s possible
 7. Progno-
sis mostly depends on how timely the diagnosis is made and
the treatment started
 8. An initial antibiotic triple therapy is
suggested, so that the specter of gram-positive, gram-negative
and anaerobic bacteria is covered
 3. The radically achieved de-
bridement of the affected surfaces is done without delay, be-
cause the untreated gangrene spreads with the speed of 3 cm/h
until it reaches the supraclavicular fossa
 9. The surgical treat-
ment consists, besides the removal of necrotic masses and
drainage of rinsing and removing of urine through the urethral
or cystostomy catheter. In 2001, Kovacs et al. 
10 published a
series in which they recognized a better treatment result via
vacuum-assisted closure (VAC) of the wound. Many urolo-
gists consider VAC procedure as a part of standard treatment.
The term HBO treatment implies breathing 100% of oxygen
with the pressure higher than the atmosphere pressure, in a
specially designed chamber
 11. This therapy brings to an im-
provement of the perfusion of ischemic tissue, improved oxy-
gen supply, neovascularization and it also has an antimicrobic
effect which is related to anaerobic bacteria
 12. In the available
literature there is no reference to larger series of patients with
Fournier’s gangrene treated with HBO. Pizzorno et al. 
13 de-
scribed in their study on Fournier’s gangrene the treatment of
11 patients via HBO, without mortal outcomes. Korhonen et
al 
14 showed in the study involving 33 patients the positive ef-
fects of HBO in the treatment of Fournier’s gangrene, con-
cluding that this method of the treatment allows the tissue
preservation and the decrease of the mortality rate. On the
other hand, there are studies that have not proved the advan-
tage of HBO usage in the treatment of Fournier’s gangrene 
15.
In the Urology Clinic, Medical Military Academy, Bel-
grade, six patients with FG have been hospitalized since the
year 2000. Here we reported, to our opinion, the most inter-
esting case due to enormous comorbidity, bad condition of
the patient’s and defects on the urethra that requested recon-
structive procedures also done in the field of diabetic micro-
angiopathy and secondary thrombocythopeny, and even so
the used method of treatment gave exellent results. We think
that HBO treatment had excellent outcome in this patient be-
cause he also had FG diabetic microangiopathy and prior
pulmonal thromboembolysm and myocardial infarction. The
first hospitalization lasted 58 days because shortly after the
primary surgery heart failure, atrial fibrillation and pulmo-
nary thromboembolism occurred. After we overcame these
vital threatened disorders, the patient took HBO treatment
three times per week, in ten times. This HBO treatment was
also done in the first hospitalization. Both times the delayed
urethral reconstruction was caused by bad health of the pa-
tient and numerous comorbidities, which were the reasons
for preoperative internal management and therapy to need a
longer time period.
Conclusion
A patient with numerous and serious comorbid condi-
tions with FG could recover as a result of a teamwork of
urologists, infective medicine specialists, cardiologists, en-
docrinologist, vascular and plastic surgeons.
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